An updated practical guideline on use of molnupiravir and comparison with agents having emergency use authorization for treatment of COVID-19-Reference-Cited by-同舟云学术

An updated practical guideline on use of molnupiravir and comparison with agents having emergency use authorization for treatment of COVID-19

Published:2022-02 Issue:2 Volume:16 Page:102396
ISSN:1871-4021
Container-title:Diabetes & Metabolic Syndrome: Clinical Research & Reviews
language:en
Short-container-title:Diabetes & Metabolic Syndrome: Clinical Research & Reviews

Author:

Singh Awadhesh Kumar^ORCID,Singh Akriti,Singh Ritu,Misra Anoop

Publisher

Elsevier BV

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference29 articles.

1. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network — United States, March–June 2020;Tenforde;MMWR Morb Mortal Wkly Rep,2020

2. New COVID-19 cases and hospitalizations among adults, by vaccination status — New York, May 3–July 25, 2021;Rosenberg;MMWR Morb Mortal Wkly Rep,2021

3. Effectiveness of COVID-19 mRNA vaccines against COVID-19-associated hospitalization — five veterans affairs medical centers, United States, February 1–August 6, 2021;Bajema;MMWR Morb Mortal Wkly Rep,2021

4. Neutralizing antibody therapeutics for COVID-19;Hurt;Viruses,2021

5. Horby PW, Mafham M, Peto L, et al. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. June 16, 2021.

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Encapsulation investigation of molnupiravir drug guest using cucurbituril hosts through the DFT approach;Journal of Inclusion Phenomena and Macrocyclic Chemistry;2024-07-02

2. Prevention is better than healing. Clinical and economic implications of oral antiviral agents in COVID-19: a prospective study;Italian Journal of Medicine;2024-06-03

3. A path from synthesis to emergency use authorization of molnupiravir as a COVID-19 therapy;Bioorganic Chemistry;2024-06

4. Eco‐Friendly Analytical Approaches for the Quantification of Molnupiravir and Favipiravir Using Capillary Zone Electrophoresis and Derivative Ratio Spectrophotometry;ChemistrySelect;2024-05-22

5. Proof-of-concept studies with a computationally designed M ^pro inhibitor as a synergistic combination regimen alternative to Paxlovid;Proceedings of the National Academy of Sciences;2024-04-15